["[Tab] Johnson & Johnson Consolidated Statements of Earnings\n\n[Time]: 2023 [SEP]\n[row 0]: Sales to customers [SEP]\n[row 1]: Cost of products sold | $26,553 [SEP]\n[row 2]: Gross profit | $58,606 [SEP]\n[row 3]: Selling, marketing and administrative expenses | $21,512 [SEP]\n[row 4]: Research and development expense | $15,085 [SEP]\n[row 5]: In-process research and development impairments |  ￥313 [SEP]\n[row 6]: Interest income | ($1,261) [SEP]\n[row 7]: Interest expense, net of portion capitalized | 772 [SEP]\n[row 8]: Other (income) expense, net | 6,634 [SEP]\n[row 9]: Restructuring | $489 [SEP]\n[row 10]: Earnings before provision for taxes on income | $15,062 [SEP]\n[row 11]: Provision for taxes on income | $1,736 [SEP]\n[row 12]: Net earnings from continuing operations | $13,326 [SEP]\n[row 13]: Net earnings from discontinued operations, net of tax | $21,827 [SEP]\n[row 14]: Net earnings | $35,153 [SEP]\n\n[row 15]: Net earnings per share (Notes 1 and 15) [SEP]\n[row 16]: Continuing operations - basic | $5.26 [SEP]\n[row 17]: Discontinued operations - basic | $8.62 [SEP]\n[row 18]: Total net earnings per share - basic | $13.88 [SEP]\n\n[row 19]: Total net earnings per share - diluted [SEP]\n[row 20]: Continuing operations - diluted | $5.20 [SEP]\n[row 21]: Discontinued operations - diluted | $8.52 [SEP]\n[row 22]: Total net earnings per share - diluted | $13.72 [SEP]\n\n[row 23]: Average shares outstanding (Notes 1 and 15) [SEP]\n[row 24]: Basic | 2,533.5 [SEP]\n[row 25]: Diluted | 2,560.4 [SEP]\n\n[Time]: 2022 [SEP]\n[row 0]: Sales to customers [SEP]\n[row 1]: Cost of products sold | $24,596 [SEP]\n[row 2]: Gross profit | $55,394 [SEP]\n[row 3]: Selling, marketing and administrative expenses | $20,246 [SEP]\n[row 4]: Research and development expense | $14,135 [SEP]\n[row 5]: In-process research and development impairments |  ￥783 [SEP]\n[row 6]: Interest income | ($490) [SEP]\n[row 7]: Interest expense, net of portion capitalized | $276 [SEP]\n[row 8]: Other (income) expense, net | $810 [SEP]\n[row 9]: Restructuring | $275 [SEP]\n[row 10]: Earnings before provision for taxes on income | $19,359 [SEP]\n[row 11]: Provision for taxes on income | $2,989 [SEP]\n[row 12]: Net earnings from continuing operations | $16,370 [SEP]\n[row 13]: Net earnings from discontinued operations, net of tax | $1,571 [SEP]\n[row 14]: Net earnings | $17,941 [SEP]\n\n[row 15]: Net earnings per share (Notes 1 and 15) [SEP]\n[row 16]: Continuing operations - basic | $6.23 [SEP]\n[row 17]: Discontinued operations - basic | $0.60 [SEP]\n[row 18]: Total net earnings per share - basic | $6.83 [SEP]\n\n[row 19]: Total net earnings per share - diluted [SEP]\n[row 20]: Continuing operations - diluted | $6.14 [SEP]\n[row 21]: Discontinued operations - diluted | $0.59 [SEP]\n[row 22]: Total net earnings per share - diluted | $6.73 [SEP]\n\n[row 23]: Average shares outstanding (Notes 1 and 15) [SEP]\n[row 24]: Basic | 2,625.2 [SEP]\n[row 25]: Diluted | 2,663.9 [SEP]\n\n[Time]: 2021 [SEP]\n[row 0]: Sales to customers [SEP]\n[row 1]: Cost of products sold | $23,402 [SEP]\n[row 2]: Gross profit | $55,338 [SEP]\n[row 3]: Selling, marketing and administrative expenses | $20,118 [SEP]\n[row 4]: Research and development expense | $14,277 [SEP]\n[row 5]: In-process research and development impairments |  $900 [SEP]\n[row 6]: Interest income | ($53) [SEP]\n[row 7]: Interest expense, net of portion capitalized | $183 [SEP]\n[row 8]: Other (income) expense, net | $526 [SEP]\n[row 9]: Restructuring | $209 [SEP]\n[row 10]: Earnings before provision for taxes on income | $19,178 [SEP]\n[row 11]: Provision for taxes on income | $1,377 [SEP]\n[row 12]: Net earnings from continuing operations | $17,801 [SEP]\n[row 13]: Net earnings from discontinued operations, net of tax | $3,077 [SEP]\n[row 14]: Net earnings | $20,878 [SEP]\n\n[row 15]: Net earnings per share (Notes 1 and 15) [SEP]\n[row 16]: Continuing operations - basic | $6.76 [SEP]\n[row 17]: Discontinued operations - basic | $1.17 [SEP]\n[row 18]: Total net earnings per share - basic | $7.93 [SEP]\n\n[row 19]: Total net earnings per share - diluted [SEP]\n[row 20]: Continuing operations - diluted | $6.66 [SEP]\n[row 21]: Discontinued operations - diluted | $1.15 [SEP]\n[row 22]: Total net earnings per share - diluted | $7.81 [SEP]\n\n[row 23]: Average shares outstanding (Notes 1 and 15) [SEP]\n[row 24]: Basic | 2,632.1 [SEP]\n[row 25]: Diluted | 2,674.0 [SEP]"]